1. Home
  2. EW

EW

Edwards Lifesciences Corporation

Logo Edwards Lifesciences Corporation

Health Care

Industrial Specialties

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.

Founded: 1958 Country:
United States
United States
Employees: N/A City: IRVINE
Market Cap: 54.3B IPO Year: 2000
Target Price: $92.82 AVG Volume (30 days): 4.0M
Analyst Decision: Buy Number of Analysts: 18
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 2.30 EPS Growth: -5.74
52 Week Low/High: $60.57 - $96.12 Next Earning Date: 04-25-2024
Revenue: $6,004,800,000 Revenue Growth: 11.56%
Revenue Growth (this year): 11.83% Revenue Growth (next year): 9.84%

Share on Social Networks: